BCL3 Antikörper (AA 341-454) (Cy7)
-
- Target Alle BCL3 Antikörper anzeigen
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
-
Bindungsspezifität
- AA 341-454
-
Reaktivität
- Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL3 Antikörper ist konjugiert mit Cy7
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Maus
- Homologie
- Human,Rat,Dog,Cow,Pig
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human Bcl3
- Isotyp
- IgG
- Top Product
- Discover our top product BCL3 Primärantikörper
-
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 300-400) antibody
BCL3 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 362-454) antibodyBCL3 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 249-277), (Center) antibodyBCL3 Reaktivität: Human, Maus WB, FACS, IF, IHC (p) Wirt: Kaninchen Polyclonal RB23954 unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (C-Term) antibodyBCL3 Reaktivität: Human WB, ELISA, IHC, IP, FACS, FM Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 248-277), (Middle Region) antibodyBCL3 Reaktivität: Human, Maus WB, FACS, IF, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 82-341) antibodyBCL3 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) antibodyBCL3 Reaktivität: Human WB, ICC, DB Wirt: Maus Monoclonal 2069E2a unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 1-446) antibodyBCL3 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 1-446) antibodyBCL3 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 3 (BCL3) (AA 2-13) antibodyBCL3 Reaktivität: Human WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
- Andere Bezeichnung
- Bcl3 (BCL3 Produkte)
- Synonyme
- BCL3 antikoerper, AI528691 antikoerper, Bcl-3 antikoerper, BCL4 antikoerper, D19S37 antikoerper, B-cell CLL/lymphoma 3 antikoerper, B cell leukemia/lymphoma 3 antikoerper, BCL3 antikoerper, Bcl3 antikoerper
- Hintergrund
-
Synonyms: BCL4, D19S37, B-cell lymphoma 3 protein, BCL-3, Proto-oncogene BCL3, BCL3
Background: Contributes to the regulation of transcriptional activation of NF-kappa-B target genes. In the cytoplasm, inhibits the nuclear translocation of the NF-kappa-B p50 subunit. In the nucleus, acts as transcriptional activator that promotes transcription of NF-kappa-B target genes. Contributes to the regulation of cell proliferation (By similarity).
- Gen-ID
- 602
- UniProt
- P20749
- Pathways
- NF-kappaB Signalweg, Maintenance of Protein Location, Protein targeting to Nucleus
-
